Eye Firm, Optos, Developing Test for Alzheimer’s Disease

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 1 Issue 11, June 2011].

Summary

Fife-based retinal imaging company Optos has reported positive results in a screening test for Alzheimer’s Disease. The aim is to find a simple eye test which could be used to screen patients for the dementia.

Optos found a “highly significant” association between changes to the retina of the eye and the disease. The “optomap” screening test, developed by a team of scientists, identifies drusen i.e. tiny yellow or white spots on the retina. These spots are thought to signal changes in the nervous system which are likely to be linked to the putative causes of Alzheimer’s Disease.

Roy Davis, chief executive of Optos, commented:

“This latest study adds to a growing body of clinical data that supports our conviction that the optomap has a crucial role to play in the detection and monitoring of a number of diseases.”

Read more: BBC News: Eye firm, Optos, Develops Alzheimer Test.

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Diagnosis, For Researchers (mostly), In the News, Quick Insights, Universal Interest and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.